$20.86

+0.07 (+0.34%)

NASDAQ · Healthcare · Biotechnology · $202.1M mcap · Short 74% of daily vol

Credit Risk of going bust: not rated Debt: 95.8% of company value Bonds: none of note held by US funds details ▾

Not rated: no recent balance sheet.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Revenue Segmentation

By Product / Service

Income Trends

Revenue

$8.2B -4.0% ▼

5Y CAGR: -1.6%

Gross Profit

$5.7B -0.1% ▼

5Y CAGR: -0.8%

Operating Income

$2.9B +8.4% ▲

5Y CAGR: +6.4%

Net Income

$1.8B +9.7% ▲

5Y CAGR: +13.5%

EPS (Diluted)

$0.00 +0.0% ▲

EBITDA

$3.8B -5.2% ▼

5Y CAGR: -1.0%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2015	FY2016	FY2017	FY2018	FY2019
Revenue	$9.0B	$8.9B	$8.6B	$8.5B	$8.2B
YoY Growth	+1.4%	-0.6%	-4.0%	-0.7%	-4.0%
Cost of Revenue	$2.9B	$2.9B	$2.9B	$2.8B	$2.4B
Gross Profit	$6.1B	$6.0B	$5.7B	$5.7B	$5.7B
Gross Margin	68.0%	67.1%	66.3%	67.4%	70.1%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$1.0B	$1.0B	$925M	$799M	$659M
Operating Expenses	$6.7B	$6.6B	$6.2B	$5.8B	$659M
Operating Income	$2.3B	$2.3B	$2.3B	$2.7B	$2.9B
Operating Margin	25.2%	26.1%	27.1%	31.3%	35.4%
Interest Expense	$473M	$478M	$465M	$448M	$0
Income Before Tax	$1.7B	$1.8B	$1.8B	$2.2B	$2.5B
Tax Expense	$659M	$678M	$134M	$494M	$641M
Net Income	$1.1B	$1.1B	$1.7B	$1.7B	$1.8B
Net Margin	12.0%	12.2%	19.4%	19.6%	22.4%
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	$0.00
EBITDA	$4.0B	$3.9B	$3.8B	$4.0B	$3.8B
Shares Outstanding	0	0	0	0	0

Line Item	FY2018 Q3	FY2018 Q4	FY2019 Q1	FY2019 Q2	FY2019 Q3	FY2019 Q4	FY2020 Q1	FY2020 Q2
Revenue	$2.1B	$2.1B	$2.1B	$2.1B	$2.0B	$2.0B	$1.9B	$524M
Cost of Revenue	$697M	$661M	$607M	$588M	$630M	$613M	$473M	$490M
Gross Profit	$1.5B	$1.5B	$1.4B	$1.5B	$1.4B	$1.4B	$1.4B	$34M
Gross Margin	67.6%	68.7%	70.5%	71.3%	69.1%	69.5%	75.3%	6.5%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$1.4B	$1.4B	$1.3B	$1.3B	$1.3B	-$3.2B	$143M	$139M
Operating Expenses	$1.4B	$1.4B	$1.3B	$1.3B	$1.3B	-$3.2B	$143M	$139M
Operating Income	$717M	$685M	$760M	$750M	$748M	$626M	$779M	$679M
Operating Margin	33.4%	32.4%	37.0%	36.6%	36.7%	31.1%	40.6%	129.6%
Interest Expense	$112M	$98M	$95M	$96M	$95M	-$286M	$0	$0
Income Before Tax	$564M	$577M	$658M	$644M	$643M	$523M	$680M	$583M
Tax Expense	$111M	$172M	$171M	$167M	$166M	$137M	$177M	$153M
Net Income	$453M	$405M	$487M	$477M	$477M	$386M	$503M	$430M
Net Margin	21.1%	19.2%	23.7%	23.3%	23.4%	19.2%	26.2%	82.1%
EPS (Diluted)	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
EBITDA	$1.0B	$1.0B	$1.1B	$1.1B	$1.1B	$584M	$1.0B	$910M
Shares Outstanding	0	0	0	0	0	0	0	0

CTY NASDAQ

Revenue Segmentation

By Product / Service

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet